Skip to main content
Journal cover image

A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF HUMAN PLASMA DERIVED ANTITHROMBIN (ATENATIV) IN HEPARIN-RESISTANT CARDIAC SURGERY PATIENTS

Publication ,  Conference
Solomon, C; Argyle, C; Levy, JH; Werner, S
Published in: AMERICAN JOURNAL OF HEMATOLOGY
2024

Duke Scholars

Published In

AMERICAN JOURNAL OF HEMATOLOGY

EISSN

1096-8652

ISSN

0361-8609

Publication Date

2024

Volume

100

Start / End Page

120 / 121

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Solomon, C., Argyle, C., Levy, J. H., & Werner, S. (2024). A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF HUMAN PLASMA DERIVED ANTITHROMBIN (ATENATIV) IN HEPARIN-RESISTANT CARDIAC SURGERY PATIENTS. In AMERICAN JOURNAL OF HEMATOLOGY (Vol. 100, pp. 120–121).
Solomon, Cristina, Catrin Argyle, Jerrold H. Levy, and Sylvia Werner. “A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF HUMAN PLASMA DERIVED ANTITHROMBIN (ATENATIV) IN HEPARIN-RESISTANT CARDIAC SURGERY PATIENTS.” In AMERICAN JOURNAL OF HEMATOLOGY, 100:120–21, 2024.
Journal cover image

Published In

AMERICAN JOURNAL OF HEMATOLOGY

EISSN

1096-8652

ISSN

0361-8609

Publication Date

2024

Volume

100

Start / End Page

120 / 121

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology